NCT01820416

Brief Summary

The purpose of this study is to determine whether low-level laser therapy can improve hearing thresholds in individuals with hearing loss. Subjects will be randomly assigned to a treatment, placebo, or control group. The treatment group will be given a three treatment of low-level laser therapy, which consists of shining low-level lasers beams onto the ear and head. The laser beams are cool to the touch, and do not cause discomfort. Each laser treatment will last approximately 4 minutes. Three treatments will be applied three times within the course of one week. Hearing tests will be administered immediately before treatment, immediately after treatment, and six weeks after treatment. Results will be analyzed to determine the effect of the laser treatment on hearing.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
35

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2009

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2009

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2009

Completed
3.3 years until next milestone

First Submitted

Initial submission to the registry

March 25, 2013

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 28, 2013

Completed
4.2 years until next milestone

Results Posted

Study results publicly available

June 1, 2017

Completed
Last Updated

June 1, 2017

Status Verified

April 1, 2017

Enrollment Period

3 months

First QC Date

March 25, 2013

Results QC Date

March 1, 2017

Last Update Submit

April 26, 2017

Conditions

Keywords

Hearing Loss, BilateralHearing Loss, Sensorineural

Outcome Measures

Primary Outcomes (1)

  • Change in Speech Perception

    Hearing status, as assessed by the Connected Sentence Test (CST). Difference scores (post-test - pretest) are reported. The CST approximates everyday conversation. Scoring is based on the number of correctly repeated key words. Higher numbers indicate better scores. The minimum score is 0 (0%) and the maximum is 100 (100%). When comparing test-retest scores for an individual, Cox et al. (1988) suggest that changes of 15% or more (based on 100 key words) are indicative of significant changes. We subtracted the post-test from the pre-test, so that negative difference scores indicate worse performance, and positive difference scores indicate better performance. Difference scores with an absolute value smaller than 15 are interpreted as no significant change. In addition, pre- and post-test performance was assessed for groups using t-tests on the difference scores.

    7-10 days after baseline measures recorded

Study Arms (3)

Low-Level Laser Therapy

EXPERIMENTAL

Low-level laser applied for approximately 4 minutes to the area around the pinna, the back of the neck, and the top of the head.

Radiation: Low-level Laser Therapy

Disabled Laser

PLACEBO COMPARATOR

Low-level laser device with laser diodes disabled. Also applied for approximately 4 minutes to the area around the pinna, the back of the neck, and the top of the head.

Other: Placebo Comparator: Disabled Laser

Control

NO INTERVENTION

Visit laboratory using same schedule as experiment and placebo. No Low-level laser or any treatment applied. Used to assess normal test-retest variability.

Interventions

Portable unit containing two laser diodes producing 532 and 635 nm wavelengths. Both diodes produced energy levels of 7.5 mw (class IIIb). Beams from both diodes were dispersed through lenses to create parallel line-generated beams, rather than spots. The 532 nm light was constant, and the 635 nm light was pulsed, with frequencies of 15 and 33 Hz. The pulsing alternated between frequencies every 30 seconds.

Also known as: Erchonia EHL laser (Erchonia Medical, Inc.)
Low-Level Laser Therapy

Portable unit containing two DISABLED laser diodes. Same protocol was followed as for the Experimental (radiation) group, except that the disabled diodes produced no radiation.

Disabled Laser

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • bilateral sensorineural hearing loss
  • normal middle ear status

You may not qualify if:

  • pregnant or lactating
  • serious mental health illness or medical/psychiatric hospitalization
  • treatment with cancer chemotherapeutic agents or aminoglycoside antibiotics
  • taking Aspirin, Ibuprofen, Naprosyn, Aleve
  • taking any Quinine-related drugs
  • taking any loop diuretics
  • have a developmental disability or cognitive impairment
  • history of drug abuse
  • involved in litigation or claim related to hearing loss
  • regularly exposed to significant occupational or recreational noise
  • have a photosensitivity disorder
  • have a retinal disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Iowa

Iowa City, Iowa, 52242, United States

Location

Related Publications (1)

  • Goodman SS, Bentler RA, Dittberner A, Mertes IB. The effect of low-level laser therapy on hearing. ISRN Otolaryngol. 2013 Apr 23;2013:916370. doi: 10.1155/2013/916370. eCollection 2013.

MeSH Terms

Conditions

Hearing LossHearing Loss, BilateralHearing Loss, Sensorineural

Interventions

Low-Level Light Therapy

Condition Hierarchy (Ancestors)

Hearing DisordersEar DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Laser TherapyTherapeuticsPhototherapy

Results Point of Contact

Title
Shawn S Goodman
Organization
Dept. of Communication Sciences & Disorders, University of Iowa

Study Officials

  • Shawn S Goodman, PhD

    University of Iowa

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

March 25, 2013

First Posted

March 28, 2013

Study Start

September 1, 2009

Primary Completion

December 1, 2009

Study Completion

December 1, 2009

Last Updated

June 1, 2017

Results First Posted

June 1, 2017

Record last verified: 2017-04

Locations